Rakovina Therapeutics Inc (RKV) Price & Analysis

22 Followers

RKV Stock Chart & Stats

C$0.20

C$0.00(0.00%)

At close: Jul 27 4:00 PM EDT

C$0.20

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.09 - C$0.32

Previous CloseN/A

Volume3.81K

Average Volume (3M)24.45K

Market Cap

C$5.49M

Enterprise ValueC$6.63M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.91

Next Earnings

Nov 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.07

Shares Outstanding24,413,624

10 Day Avg. Volume22,608

30 Day Avg. Volume24,454

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)1.1

Revenue Forecast (FY)C$30.00M

Rakovina Therapeutics Inc News

Rakovina taps Celvion’s AI platform to sharpen precision oncology strategy

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has issued an update. Rakovina Therapeutics has entered a research collaboration with...

11d ago

Rakovina Therapeutics Adds Yale DNA Repair Expert to Scientific Advisory Board

Rakovina Therapeutics Inc ( ($TSE:RKV) ) just unveiled an announcement. Rakovina Therapeutics has appointed Yale physician-scientist and biotech...

25d ago

Rakovina Therapeutics Narrows Q2 Loss as AI-Focused Cancer Pipeline Advances

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has shared an update. Rakovina Therapeutics reported Q2 2026 results showing research...

1M ago

Rakovina Therapeutics Closes Upsized $1.99 Million Private Placement to Advance AI-Driven Cancer Pipeline

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has shared an announcement. Rakovina Therapeutics has completed the second and final...

1M ago

Rakovina Therapeutics Tightens Board, Keeps Incentive Plan as It Advances AI-Driven Cancer Pipeline

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has issued an update. Rakovina Therapeutics Inc., a Vancouver-based biopharmaceutical company listed...

2M ago

Methanex Declares Quarterly Dividend, Reinforcing Shareholder Payout Strategy

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has shared an announcement. Methanex Corporation’s board of directors has declared a...

3M ago

Rakovina leverages AI to advance next‑generation cancer drug candidates

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has issued an update. Rakovina Therapeutics will present two AI-enabled oncology programs...

7M ago

Rakovina Therapeutics Extends Private Placement to Bolster Working Capital

Rakovina Therapeutics Inc ( ($TSE:RKV) ) just unveiled an update. Rakovina Therapeutics Inc., a biopharmaceutical firm specializing in...

7M ago

Rakovina Raises $1 Million and Restructures Debt to Bolster Cancer Drug Development

Rakovina Therapeutics Inc ( ($TSE:RKV) ) just unveiled an announcement. Rakovina Therapeutics has closed a non-brokered private placement...

7M ago

Rakovina Therapeutics Upsizes Financing to $2 Million for Near-Term Operations

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has issued an announcement. Rakovina Therapeutics has upsized its previously announced financing...

8M ago

RKV FAQ

What was Rakovina Therapeutics Inc’s price range in the past 12 months?

Rakovina Therapeutics Inc lowest stock price was C$0.09 and its highest was C$0.32 in the past 12 months.

What is Rakovina Therapeutics Inc’s market cap?

Rakovina Therapeutics Inc’s market cap is C$5.49M.

When is Rakovina Therapeutics Inc’s upcoming earnings report date?

Rakovina Therapeutics Inc’s upcoming earnings report date is Nov 26, 2026 which is in 45 days.

How were Rakovina Therapeutics Inc’s earnings last quarter?

Rakovina Therapeutics Inc released its earnings results on Aug 31, 2026. The company reported -C$0.07 earnings per share for the quarter.

Is Rakovina Therapeutics Inc overvalued?

According to Wall Street analysts Rakovina Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Rakovina Therapeutics Inc pay dividends?

Rakovina Therapeutics Inc does not currently pay dividends.

What is Rakovina Therapeutics Inc’s EPS estimate?

Rakovina Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Rakovina Therapeutics Inc have?

Rakovina Therapeutics Inc has 24,413,624 shares outstanding.

What happened to Rakovina Therapeutics Inc’s price movement after its last earnings report?

Rakovina Therapeutics Inc reported an EPS of -C$0.07 in its last earnings report. Following the earnings report the stock price went up 28.571%.

Which hedge fund is a major shareholder of Rakovina Therapeutics Inc?

Currently, no hedge funds are holding shares in TSE:RKV

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Rakovina Therapeutics Inc

Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded on May 6, 2019 and is headquartered in Vancouver, Canada.